University of SaskatchewanHARVEST
  • Login
  • Submit Your Work
  • About
    • About HARVEST
    • Guidelines
    • Browse
      • All of HARVEST
      • Communities & Collections
      • By Issue Date
      • Authors
      • Titles
      • Subjects
      • This Collection
      • By Issue Date
      • Authors
      • Titles
      • Subjects
    • My Account
      • Login
      JavaScript is disabled for your browser. Some features of this site may not work without it.
      View Item 
      • HARVEST
      • Electronic Theses and Dissertations
      • Graduate Theses and Dissertations
      • View Item
      • HARVEST
      • Electronic Theses and Dissertations
      • Graduate Theses and Dissertations
      • View Item

      The Impact of Rapamycin and Metformin on Genome Organization and Function in Normal Human Fibroblasts

      Thumbnail
      View/Open
      GILLESPIE-THESIS-2016.pdf (7.089Mb)
      Date
      2017-01-24
      Author
      Gillespie, Zoe Elizabeth 1993-
      ORCID
      0000-0003-1632-4504
      Type
      Thesis
      Degree Level
      Masters
      Metadata
      Show full item record
      Abstract
      For decades, dietary restriction (DR) has been documented to extend health and lifespan across numerous model organisms. Two compounds, rapamycin (an immuno-suppressant) and metformin (a drug used to treat type II diabetes) have been proposed to mimic these health and lifespan benefits. Interestingly, DR, rapamycin and metformin result in the inhibition of the mammalian target of rapamycin (mTOR), a major nutrient sensing and signalling hub in the cell. The unexpected side-effect of this inhibition is the proposed extension in both health and lifespan in cell cultures and organisms. Despite the impact of inhibiting mTOR being well established at the biochemical level, the impact of mTOR inhibition on genome function (gene expression) and organization (organization of the genome in three-dimensional space) is poorly understood. Normal human fibroblasts were grown in culture and treated with either rapamycin or metformin for 120 h. It was established that with both treatments applied individually, population doubling times increased with no evidence of cell death; however, cellular morphology was divergent, with rapamycin-treated fibroblasts reminiscent of quiescence, whilst metformin-treated fibroblasts still exhibited the morphology of proliferating cells. Analysis of chromosome territory positioning revealed similar re-location of chromosomes 18 and 10 whilst RNA sequencing analyses demonstrated divergent transcript profiles. In particular, transcripts changing significantly in response to rapamycin treatment were enriched for the cytokine-cytokine receptor interaction pathway, whilst genes changing significantly in response to metformin were enriched in the AP-1 transcription factor pathway. Chromatin immuno-precipitation analyses revealed STAT5A/B as a potential mediator of rapamycin-mediated changes in gene expression. Together, these data demonstrated that although rapamycin and metformin are potential mimetics of DR, they elicit differential changes in gene expression and function through divergent mechanisms. Finally, these findings indicate that there are multiple targets for treatments which could result in increased health and lifespan in humans.
      Degree
      Master of Science (M.Sc.)
      Department
      Food and Bioproduct Sciences
      Program
      Food Science
      Supervisor
      Eskiw, Christopher H
      Committee
      Bonham, Keith; Low, Nicholas; Eames, Brian; Qiu, Xiao
      Copyright Date
      December 2016
      URI
      http://hdl.handle.net/10388/7709
      Subject
      Genome Organization, Genome Function, Rapamycin, Metformin, Dietary Restriction, Transcriptomics, RNAseq, Fibroblasts
      Collections
      • Graduate Theses and Dissertations
      University of Saskatchewan

      University Library

      © University of Saskatchewan
      Contact Us | Disclaimer | Privacy